BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 20180534)

  • 1. Discovery of a novel series of semisynthetic vancomycin derivatives effective against vancomycin-resistant bacteria.
    Nakama Y; Yoshida O; Yoda M; Araki K; Sawada Y; Nakamura J; Xu S; Miura K; Maki H; Arimoto H
    J Med Chem; 2010 Mar; 53(6):2528-33. PubMed ID: 20180534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidation of the active conformation of vancomycin dimers with antibacterial activity against vancomycin-resistant bacteria.
    Nakamura J; Yamashiro H; Hayashi S; Yamamoto M; Miura K; Xu S; Doi T; Maki H; Yoshida O; Arimoto H
    Chemistry; 2012 Oct; 18(40):12681-9. PubMed ID: 22915313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of rigidly-linked vancomycin dimers and their in vivo efficacy against resistant bacteria.
    Lu J; Yoshida O; Hayashi S; Arimoto H
    Chem Commun (Camb); 2007 Jan; (3):251-3. PubMed ID: 17299629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recent advances in the study of synthesis and activity of vancomycin derivatives].
    Chen YY; Liu G
    Yao Xue Xue Bao; 2007 May; 42(5):463-9. PubMed ID: 17703765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid-phase synthesis and antibacterial activity of hydroxycinnamic acid amides and analogues against methicillin-resistant Staphylococcus aureus and vancomycin-resistant S. aureus.
    Yingyongnarongkul BE; Apiratikul N; Aroonrerk N; Suksamrarn A
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5870-3. PubMed ID: 16942872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of bis, tris and tetra(dihydrocaffeoyl)polyamine conjugates as antibacterial agents against VRSA.
    Yingyongnarongkul BE; Apiratikul N; Aroonrerk N; Suksamrarn A
    Arch Pharm Res; 2008 Jun; 31(6):698-704. PubMed ID: 18563350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid-phase synthesis and antibacterial evaluations of N-demethylvancomycin derivatives.
    Yao NH; Liu G; He WY; Niu C; Carlson JR; Lam KS
    Bioorg Med Chem Lett; 2005 May; 15(9):2325-9. PubMed ID: 15837318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antibacterial evaluation of novel 8-fluoro Norfloxacin derivatives as potential probes for methicillin and vancomycin-resistant Staphylococcus aureus.
    Sunduru N; Gupta L; Chauhan K; Mishra NN; Shukla PK; Chauhan PM
    Eur J Med Chem; 2011 Apr; 46(4):1232-44. PubMed ID: 21345548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative activity of the new lipoglycopeptide telavancin in the presence and absence of serum against 50 glycopeptide non-susceptible staphylococci and three vancomycin-resistant Staphylococcus aureus.
    Leuthner KD; Cheung CM; Rybak MJ
    J Antimicrob Chemother; 2006 Aug; 58(2):338-43. PubMed ID: 16787952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Non-natural aglycones of glycopeptide antibiotics of the vancomycin group. Synthesis and antibacterial activity].
    Pavlov AIu; Olsuf'eva EN; Miroshnikova OV; Reznikova MI; Lazhko EI; Malabarba A; Ciabatti R; Preobrazhenskaia MN
    Bioorg Khim; 1997 May; 23(5):410-21. PubMed ID: 9290051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of benzenesulfonanilides active against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus.
    Namba K; Zheng X; Motoshima K; Kobayashi H; Tai A; Takahashi E; Sasaki K; Okamoto K; Kakuta H
    Bioorg Med Chem; 2008 Jun; 16(11):6131-44. PubMed ID: 18468909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoconjugated vancomycin: new opportunities for the development of anti-VRSA agents.
    Chakraborty SP; Sahu SK; Mahapatra SK; Santra S; Bal M; Roy S; Pramanik P
    Nanotechnology; 2010 Mar; 21(10):105103. PubMed ID: 20154376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The vancomycin-nisin(1-12) hybrid restores activity against vancomycin resistant Enterococci.
    Arnusch CJ; Bonvin AM; Verel AM; Jansen WT; Liskamp RM; de Kruijff B; Pieters RJ; Breukink E
    Biochemistry; 2008 Dec; 47(48):12661-3. PubMed ID: 18989934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.
    Cafini F; Aguilar L; González N; Giménez MJ; Torrico M; Alou L; Sevillano D; Vallejo P; Prieto J
    J Antimicrob Chemother; 2007 Jun; 59(6):1185-9. PubMed ID: 17412725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antibacterial activity of 3-O-carbamoyl derivatives of 6,11-di-O-methylerythromycin A: a novel class of acylides.
    Wu Z; Lu Y; Luo M; He X; Xiao Y; Yang J; Pan Y; Qiu G; Guo H; Hu H; Zhou D; Hu X
    Eur J Med Chem; 2010 Sep; 45(9):3636-44. PubMed ID: 20554083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model.
    Jacqueline C; Caillon J; Le Mabecque V; Miègeville AF; Hamel A; Bugnon D; Ge JY; Potel G
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3397-400. PubMed ID: 17591849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel protein synthesis inhibitor active against gram-positive bacteria.
    Eibergen NR; Im I; Patel NY; Hergenrother PJ
    Chembiochem; 2012 Mar; 13(4):574-83, 490. PubMed ID: 22362659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of omiganan pentahydrochloride tested against vancomycin-tolerant, -intermediate, and -resistant Staphylococcus aureus.
    Fritsche TR; Rhomberg PR; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):399-403. PubMed ID: 18178361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin-resistant Staphylococcus aureus in the absence of vancomycin exposure.
    Whitener CJ; Park SY; Browne FA; Parent LJ; Julian K; Bozdogan B; Appelbaum PC; Chaitram J; Weigel LM; Jernigan J; McDougal LK; Tenover FC; Fridkin SK
    Clin Infect Dis; 2004 Apr; 38(8):1049-55. PubMed ID: 15095205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel semi-synthetic glycopeptide antibiotics active against methicillin-resistant staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE): doubly-modified water-soluble derivatives of chloroorienticin B.
    Yoshida O; Yasukata T; Sumino Y; Munekage T; Narukawa Y; Nishitani Y
    Bioorg Med Chem Lett; 2002 Nov; 12(21):3027-31. PubMed ID: 12372494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.